Ascendis Pharma A (ASND) FCF Margin (2014 - 2026)
Ascendis Pharma A (ASND) reported FCF Margin of 3.13% for Q1 2026, up 1105.0% on a YoY basis from 0.26% in Q1 2025, and up 87.73% sequentially from 25.52% in Q4 2025.
Ascendis Pharma A (ASND) FCF Margin (2014 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 13 years of FCF Margin data on file, last reported at 3.13% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1105.0% year-over-year to 3.13%; the trailing twelve-month figure through Mar 2026 stood at 11.52% (up 3202.0% YoY), and the FY2025 full-year result was 17.47%, up 5799.0% from the prior year.
- FCF Margin climbed to 3.13% in Q1 2026, from 25.52% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1.01% in Q3 2025 to a low of 1958.88% in Q2 2022.
- A 5-year average of 383.31% and a median of 105.72% in 2024 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 896274 bps in 2022, while the deepest fall reached 40288 bps in 2022.
- Tracing ASND's FCF Margin over 5 years: stood at 597.85% in 2022, then jumped by 98 bps to 14.05% in 2023, then plunged by 100 bps to 28.12% in 2024, then rose by 9 bps to 25.52% in 2025, then jumped by 88 bps to 3.13% in 2026.
- Business Quant data shows ASND's FCF Margin at 3.13% in Q1 2026, 25.52% in Q4 2025, and 1.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | -3.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.13% |
| Dec 31, 2025 | -25.52% |
| Sep 30, 2025 | 1.01% |
| Jun 30, 2025 | -4.64% |
| Mar 31, 2025 | -14.18% |
| Dec 31, 2024 | -28.12% |
| Sep 30, 2024 | -96.25% |
| Jun 30, 2024 | -169.36% |
| Mar 31, 2024 | -105.72% |
| Dec 31, 2023 | -14.05% |
| Sep 30, 2023 | -257.62% |
| Jun 30, 2023 | -322.17% |
| Mar 31, 2023 | -434.54% |
| Dec 31, 2022 | -597.85% |
| Sep 30, 2022 | -625.70% |
| Jun 30, 2022 | -1,958.88% |
| Mar 31, 2022 | -1,859.55% |
| Dec 31, 2021 | -194.97% |
| Sep 30, 2021 | -7,746.54% |
| Jun 30, 2021 | -10,921.62% |